HCWB Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

7.00M

+1541.57%

-1.770

-44.69%

0.00

-100%

-1.950

+3800%

-0.850

-87.48%

Estimates Revision

The market is revising No Change the revenue expectations for HCW Biologics Inc. (HCWB) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -58.70%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-58.70%

In Past 3 Month

1 Analyst Rating

Wall Street analysts forecast HCWB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HCWB is 35.00 USD with a low forecast of 35.00 USD and a high forecast of 35.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 1.780

Low

35.00

Averages

35.00

High

35.00

Current: 1.780

Low

35.00

Averages

35.00

High

35.00

Maxim

Buy

downgrade

$120 -> $35

2025-05-29

Reason

Maxim

Price Target

$120 -> $35

2025-05-29

downgrade

Buy

Reason

Maxim lowered the firm's price target on HCW Biologics to $35 from $120 but keeps a Buy rating on the shares. The firm cites the company's Q1 results and equity raise in adjusting its price target but also notes that HCW has made considerable progress in shoring up its balance sheet and advancing its pipeline following a challenging legal issue and arbitration, the analyst tells investors in a research note. The company should now have the capital to advance its pipeline and drive a turnaround in share value, Maxim added.

Valuation Metrics

The current forward P/E ratio for HCW Biologics Inc (HCWB.O) is -0.32, compared to its 5-year average forward P/E of -2.83. For a more detailed relative valuation and DCF analysis to assess HCW Biologics Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-2.83

Current PE

-0.32

Overvalued PE

-1.02

Undervalued PE

-4.63

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-0.84

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.26

Undervalued EV/EBITDA

-1.94

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

251.63

Current PS

0.00

Overvalued PS

1119.25

Undervalued PS

-616.00

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

HCWB News & Events

Events Timeline

No data

News

5.0

10-22Newsfilter

HCW Biologics Inc. (NASDAQ: HCWB) Engages in Virtual Investor "What This Means" Discussion

1.0

10-16Newsfilter

HCW Biologics Scientists to Showcase Three Posters at the 40th Annual Society for Immunotherapy of Cancer Meeting

7.5

09-18PRnewswire

Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics

People Also Watch

Frequently Asked Questions

What is HCW Biologics Inc (HCWB) stock price today?

The current price of HCWB is 1.78 USD — it has decreased -4.61 % in the last trading day.

What is HCW Biologics Inc (HCWB)'s business?

HCW Biologics Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases, such as cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, autoimmune diseases, as well as other conditions. It has developed a Tissue factOr-Based fusion (TOBI) discovery platform to generate designer, novel multi-functional fusion molecules with immunotherapeutic properties. Its lead product candidates include HCW9218 and HCW9302. HCW9218 is a clinical-stage bifunctional molecule that is designed to impact senescence by reducing senescent cells. The Company is prepared to progress HCW9218 in Phase II clinical trials for non-oncology indications.HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes. Its other product candidates include HCW9201, HCW9206, HCW11-006, and others.

What is the price predicton of HCWB Stock?

What is HCW Biologics Inc (HCWB)'s revenue for the last quarter?

HCW Biologics Inc revenue for the last quarter amounts to 15.61K USD, decreased -96.34 % YoY.

What is HCW Biologics Inc (HCWB)'s earnings per share (EPS) for the last quarter?

HCW Biologics Inc. EPS for the last quarter amounts to -2.02 USD, decreased -51.09 % YoY.

What changes have occurred in the market's expectations for HCW Biologics Inc (HCWB)'s fundamentals?

How many employees does HCW Biologics Inc (HCWB). have?

HCW Biologics Inc (HCWB) has 36 emplpoyees as of December 17 2025.

What is HCW Biologics Inc (HCWB) market cap?

Today HCWB has the market capitalization of 4.81M USD.